Blood Transfusion Diagnostics Market by Product (Instruments and Kits & Reagents), Application (Blood Group Typing and Disease Screening), End User and Geography - Global Industry Analysis, Opportunities and Forecast up to 2026

The global blood transfusion diagnostics market size was valued at $4.06 billion in 2020, and is projected to reach $6.51 billion by 2026, growing at a CAGR of 8.2% during the forecast period.

• The blood transfusion diagnostics market is expected to witness significant growth in the future due to increasing awareness regarding blood safety from infectious diseases and rising patient pool with chronic ailments.

• Additionally, the rising prevalence of chronic diseases, such as severe anemia, cancer, hemophilia, kidney disease, liver disease, severe infection, sickle cell disease, and thrombocytopenia has led to high demand for blood transfusion diagnostics. This is expected to be a high impact rendering driver, thus fostering market growth.

• Moreover, according to the National Heart, Lung, and Blood Institute, anemia is one of the most common blood disorders. The majority of the cases are due to iron deficiency. Thus, there arises the need for RBC transfusions, which is further expected to lead to a high demand for transfusion diagnostics.

• However, lack of infrastructure, lack of spending on healthcare infrastructure and stringent government policies, especially in emerging countries as compared to developed countries, and high cost of instrument are affecting the growth of the blood transfusion diagnostics market.

The term "blood transfusion diagnostics" refers to tests performed on blood and blood components prior to their transfusion to patients. To avoid adverse reactions or infection transmission, each blood unit must be screened for blood group type and disease screening. It's an important aspect of transfusion therapy since it gives healthcare workers important information and ensures the compatibility of donor and recipient blood samples. Blood transfusion is the intravenous transfer of blood or blood products. Blood transfusions can be used to replace blood components that have been lost. The most common blood components transfused include red blood cells, white blood cells, platelets, clotting factors, and plasma. During an emergency or a serious case of massive blood loss, these blood components are crucial to laboratories and hospitals.

By End User, the Hospital-based Laboratories Segment Holds the Dominant Position in the Market Revenue

The hospital-based laboratories segment holds the dominant position in the market revenue during the forecast period due to the increasing number of blood transfusion procedures in hospitals. Furthermore, numerous hospitals are actively introducing blood management programs in order to preserve blood units and make the transfusion procedure easier, which is projected to fuel the segment's expansion. The dominance is also due to the high number of blood transfusions performed in these settings, as well as the growing number of stand-alone blood banks and laboratories in both developed and developing countries.

By Geography, North America Region is Leading in the Global Market Place

North America led the market and is expected to maintain its leading position during the forecast period. Important growth factors include a high number of volunteer blood donors and the introduction of blood transfusion policies for safety and infectious disease testing. The United States has the largest proportion of the regional market in North America. The presence of big companies, simple availability of numerous assays, and increased public knowledge regarding blood donations are all factors that contribute to the region's dominance. According to the Community Blood Center, roughly 43,000 pints of donated blood are utilized every day in the United States and Canada.

List of the Key Players Profiled in the Market Include:
• Immucor Inc.
• Abbott
• Hoffman-La-Roche Ltd.
• Bag Healthcare Gmbh
• Ortho Clinical Diagnostics
• Diasorin S.P.A.
• Bio-Rad Laboratories
• Quotient Limited
• Biokit (Werfen)
• Danaher
• Merck KGaA
• Grifols
• Thermo Fisher Scientific, Inc
• Biomérieux
• Becton, Dickinson and Company
• Novartis AG
• Siemens Healthineers

What Can be Explored with this Research Report:
• Understand the key trends that will drive the market, challenges it faces in the current market scenario.
• Identify growth opportunities.
• Porter’s five force analysis.
• In-depth analysis of market segments, and regions/countries predicted to observed promising growth.
• Historical and forecast size of the market in terms of revenue (USD Million).
• Company profiling with key products and solution offerings, key financial information, SWOT analysis, and business strategies adopted.

Market Segmentation:

The research report includes in-depth coverage of the industry analysis with size, share, and forecast for the below segments:

Market by, Product:
• Instruments
• Kits & Reagents

Market by, Application:
• Blood Group Typing
• Disease Screening

Market by, End User:
• Hospital-based Laboratories
• Independent Laboratories & Blood Banks

Market by, Geography:
• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Table Of Content

1 Market Overview          
    1.1 Introduction      
    1.2 Research Objectives     
    1.3 Market Segmentation     
    1.4 Stakeholders       
    1.5 List of Acronyms      
            
2 Executive Summary          
            
3 Research Methodology         
    3.1 Identification of Data     
    3.2 Evaluation of Market Dynamics    
    3.3 Collaboration of Data     
    3.4 Verification and Analysis     
    3.5 Data Sources      
    3.6 Assumptions      
            
4 Market Dynamics          
    4.1 Market Drivers      
            4.1.1 Increasing awareness regarding blood safety from infectious diseases
            4.1.2 Rising Patient Pool with Chronic Ailments
    4.2 Market Restraints      
            4.2.1 High Cost of Instrument
    4.3 Market Opportunities     
            4.3.1 Demand for screened blood products
    4.4 Market Challenges      
            4.4.1 Lack of Infrastructure
    4.5 Impact of COVID-19 on Blood Transfusion Diagnostics Market  
            
5 Porter's Five Force Analysis         
    5.1 Bargaining Power of Suppliers     
    5.2 Bargaining Power of Buyers     
    5.3 Threat of New Entrants     
    5.4 Threat of Substitutes     
    5.5 Competitive Rivalry in the Market    
            
6 Global Blood Transfusion Diagnostics Market by, Product      
    6.1 Overview      
    6.2 Instruments      
    6.3 Kits & Reagents      
            
7 Global Blood Transfusion Diagnostics Market by, Application      
    7.1 Overview      
    7.2 Blood Group Typing      
    7.3 Disease Screening      
     7.3.1 Serological Disease Screening    
     7.3.2 Molecular Disease Screening    
            
8 Global Blood Transfusion Diagnostics Market by, End User      
    8.1 Overview      
    8.2 Hospital-based Laboratories     
    8.3 Independent Laboratories & Blood Banks   
            
9 Global Blood Transfusion Diagnostics Market by, Geography      
    9.1 Overview      
    9.2 North America      
    9.3 Europe       
    9.4 Asia Pacific      
    9.5 South America      
    9.6 Middle East & Africa     
            
10 Key Developments          
             
11 Company Profiling          
    11.1 Immucor Inc.      
            11.1.1 Business Overview
            11.1.2 Product/Service Offering
            11.1.3 Financial Overview
            11.1.4 SWOT Analysis
            11.1.5 Key Activities
    11.2 Abbott       
    11.3 Hoffman-La-Roche Ltd.     
    11.4 Bag Healthcare Gmbh     
    11.5 Ortho Clinical Diagnostics     
    11.6 Diasorin S.P.A.      
    11.7 Bio-Rad Laboratories     
    11.8 Quotient Limited      
    11.9 Biokit (Werfen)      
    11.10 Danaher       
    11.11 Merck KGaA      
    11.12 Grifols       
    11.13 Thermo Fisher Scientific, Inc     
    11.14 Biomérieux      
    11.15 Becton, Dickinson and Company    
    11.16 Novartis AG      
    11.17 Siemens Healthineers